These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 1824543)
1. Modulation of the antinociceptive effect of morphine by casomorphin derivatives. Becker A; Grecksch G; Matthies H Biomed Biochim Acta; 1991; 50(12):1255-60. PubMed ID: 1824543 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors. Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354 [TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related]
4. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. Rady JJ; Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196 [TBL] [Abstract][Full Text] [Related]
5. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site. Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752 [TBL] [Abstract][Full Text] [Related]
6. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
15. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse. Qi JN; Mosberg HI; Porreca F J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801 [TBL] [Abstract][Full Text] [Related]
16. Opioid peptides. Biological study of [D-MetO2] dermorphin analogues in relation to the plurality of opioid receptors. XI. Marastoni M; Salvadori S; Tomatis R; Borea PA; Bertelli G Farmaco Sci; 1987 Feb; 42(2):125-31. PubMed ID: 3032674 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156 [TBL] [Abstract][Full Text] [Related]
18. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity. McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018 [TBL] [Abstract][Full Text] [Related]
19. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. He L; Lee NM J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421 [TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats. Locke KW; Holtzman SG J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]